FPI Fellowship: Engineered AAV Vectors for Polycystic Kidney Disease Gene Therapy: Adapting to Disease Progression. (AAV-PKD)

The Renal Gene Therapy group, part of the Gene Therapy for Rare Diseases program and led by Dr. Rafael Aldabe, is seeking to recruit a predoctoral researcher for the project "Engineering of AAV vectors for the gene therapy treatment of polycystic kidney disease: adaptation to disease progression," funded by the Spanish Ministry of Science and Innovation (MICIU) 2025 I+D PID2025-176597OB-I00.

• The project will focus on analyzing genetic perturbations affecting the development of autosomal dominant polycystic kidney disease, using in vivo gene editing tools, AAV vectors, scRNA-seq, and bioinformatic analysis of single-cell results to identify elements that regulate disease progression.
• The research group in which this project will be carried out is led by Dr. Gloria González-Aseguinolaza, and the project will be directed by Dr. Rafael Aldabe.
• An FPI contract/fellowship is offered for a duration of 4 years.

FPI fellowship associated to the project: Engineered AAV Vectors for Polycystic Kidney Disease Gene Therapy: Adapting to Disease Progression. (AAV-PKD)